Metabolic & Incretin Pathway
5-Amino-1MQ
5mg · 50mgNNMT modulator for metabolic and metabolic-pathway research.
Tesamorelin
5mg · 10mgSynthetic GHRH analogue studied for visceral fat reduction and metabolic health.
AOD-9604
5mgSynthetic hGH fragment 176-191 analogue for lipid metabolism research.
HGH Frag 176-191
5mgHGH Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone studied for lipolytic activity...
Tirzepatide
10mg–60mgTirzepatide is a dual GIP and GLP-1 receptor agonist peptide studied for metabolic, glycemic, and body-composi...
MOTS-C
10mg · 40mgMitochondrial-derived peptide for metabolic regulation and cellular energy research.
SLU-PP-332
5mgSynthetic research peptide for neuromodulatory and metabolic studies.
Cagrilintide
10mgLong-acting synthetic amylin analogue for obesity and metabolic research.
Retatrutide
5mg–60mgTriple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors for advanced metabolic studies.
KLOW
80mgProprietary peptide blend for neuroprotection and mitochondrial support research.
About Metabolic & Incretin Pathway Research Peptides
This collection covers incretin and metabolic-pathway research peptides: triple-agonist compounds targeting GIP, GLP-1, and glucagon receptors, synthetic amylin analogues, and GHRH fragments, plus 5-Amino-1MQ, a small-molecule NNMT inhibitor studied in cellular-energy and NAD+ pathway research. Compounds are studied in glucose-regulation, insulin-signaling, and lipid-metabolism models. Every item is third-party tested to ≥98% HPLC purity and shipped lyophilized from our US facility. For laboratory research use only.